CIRC Biosciences, Inc.
Chicago, US · Founded 2019 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
DP
Darien ParhadExecutive
PM
Patrick MorrisExecutive
SC
Sai ChavalaNamed on SEC filing
Board
TC
Timothy CunniffBoard director
AG
Antonio GraciasinBoard directorFounder, Chief Executive Officer & Chief Investment Officer at Valor Equity Partners
JA
Jeffrey AroninBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$24.1M disclosed across 3 rounds · 2020–2024
▶$250KraisedOct 2024 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Darien ParhadExecutive Officer
- Timothy CunniffDirector
- Patrick MorrisExecutive Officer, Director
- Sai ChavalaDirector
- Antonio GraciasDirector
- Jeffrey AroninDirector
- Offering amount
- $250K
- Amount sold
- $250K
- Minimum investment
- $250K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$7MraisedMay 2024 · 19 investors · BiotechnologyRule 506(b)
▶$7MraisedMay 2024 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Darien ParhadExecutive Officer
- Timothy M. CunniffDirector
- Sai ChavalaDirector
- Patrick J MorrisExecutive Officer, Director
- Jeffrey S. AroninDirector
- Antonio J. GraciasDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$16.8MraisedDec 2020 · 3 investors · BiotechnologyRule 506(b)
▶$16.8MraisedDec 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick J MorrisExecutive Officer, Director
- Darien ParhadExecutive Officer
- Jeffrey S. AroninDirector
- Antonio J. GraciasDirector
- Sai ChavalaDirector
- Timothy M. CunniffDirector
- Offering amount
- $16.8M
- Amount sold
- $16.8M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are CIRC Biosciences, Inc.'s investors?
- CIRC Biosciences, Inc.'s investors include Valor Equity Partners.
- How much funding has CIRC Biosciences, Inc. raised?
- CIRC Biosciences, Inc. has disclosed $24.1M raised across 3 rounds.
- Where is CIRC Biosciences, Inc. headquartered?
- CIRC Biosciences, Inc. is headquartered in Chicago, US.